Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2022 Apr 28:jiac161. doi: 10.1093/infdis/jiac161

Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2

Martin Šmíd 1,2,, Luděk Berec 2,3,4, Lenka Přibylová 5, Ondřej Májek 6,7, Tomáš Pavlík 6,7, Jiří Jarkovský 6,7, Jakub Weiner 2,8, Tamara Barusová 9,10, Jan Trnka 11
PMCID: PMC9129207  PMID: 35482442

Abstract

Background

The Omicron variant of SARS-CoV-2 evades immunity conferred by vaccines and previous infections.

Methods

We used a Cox proportional hazards model and a logistic regression on individual-level population-wide data from the Czech Republic to estimate risks of infection and hospitalization, including severe states.

Results

A recent (≤ 2 months) full vaccination reached VE 43% (95% CI: 42-44) against infection by Omicron compared to 73% (CI: 72-74) against Delta. A recent booster increased VE to 56% (CI: 55-56) against Omicron infection compared to 90% (CI: 90-91) for Delta. The VE against Omicron hospitalization of a recent full vaccination was 45% (95% CI: 29-57), with a recent booster 87% (CI: 84-88). The VE against the need for oxygen therapy due to Omicron was 57% (CI: 32-72) for recent vaccination, 90% (CI: 87-92) for a recent booster. Post-infection protection against Omicron hospitalization declined from 68% (CI: 68-69) at ≤ 6 months to 13% (CI: 11-14) at > 6 months after a previous infection. The OR for Omicron relative to Delta was 0.36 (CI: 0.34-0.38) for hospitalization, 0.24 (CI: 0.22-0.26) for oxygen, and 0.24 (CI: 0.21-0.28) for ICU admission.

Discussion

Recent vaccination still brings substantial protection against severe outcome for Omicron.

Keywords: Covid-19, post-infection immunity, vaccine effectiveness, SARS-CoV-2, Omicron variant, hospitalization

Supplementary Material

jiac161_Supplementary_Data

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

jiac161_Supplementary_Data

Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES